Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.
Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSeveral key resources related to anal cancer and clinical trials have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference4%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to anal cancer, including links to MedlinePlus, clinical trials, and various health organizations, while removing the previous version 2.12.1.SummaryDifference4%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.